Early PCSK9 Inhibition in AMI Yields Plaque Regression Early PCSK9 Inhibition in AMI Yields Plaque Regression

"Go early and go low" is an expert ' s response to the imaging results from PACMAN-AMI showing plaque reduction after AMI patients received alirobumab.Medscape Medical News

Source: Medscape Radiology Headlines - April 5, 2022 Category: Radiology Tags: Cardiology News Source Type: news